Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Feb;66(2):930-5.
doi: 10.1128/JVI.66.2.930-935.1992.

Unusual structure of the human immunodeficiency virus type 1 trans-activation response element

Affiliations

Unusual structure of the human immunodeficiency virus type 1 trans-activation response element

R A Colvin et al. J Virol. 1992 Feb.

Abstract

The trans-activation response element (TAR) of human immunodeficiency virus type 1 is a structured RNA consisting of the first 60 nucleotides of all human immunodeficiency virus type 1 RNAs. Computer analyses and limited structural analyses indicated that TAR consists of a stem-bulge-loop structure. Mutational analyses showed that sequences in the bulge are required for Tat binding, whereas sequences in both the bulge and the loop are required for trans activation. In this study, we probed the structures of TAR and various mutants of TAR with chemical probes and RNases and used these methods to footprint a Tat peptide on TAR. Our data show that the structure of wild-type TAR is different from previously published models. The bulge, a Tat-binding site, consists of four nucleotides. The loop is structured, rather than simply single stranded, in a fashion reminiscent of the structures of the tetraloop 5'-UUCG-3' and the GNRA loop (C. Cheong, G. Varani, and I. Tinoco, Jr., Nature [London] 346:680-682, 1990; H.A. Heus and A. Pardi, Science 253:191-193, 1991). RNA footprint data indicate that three bases in the bulge are protected and suggest that a conformational change occurs upon Tat binding.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem J. 1963 Oct;89:127-38 - PubMed
    1. Science. 1991 Jul 12;253(5016):191-4 - PubMed
    1. EMBO J. 1990 Dec;9(12):4145-53 - PubMed
    1. Cell. 1991 Jul 12;66(1):1-3 - PubMed
    1. Nature. 1988 Jul 14;334(6178):165-7 - PubMed

Publication types

Substances

LinkOut - more resources